Intravenous Infusions (XGHA:IIL) FCF Yield % : 0.00 (As of Jun. 20, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Intravenous Infusions FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Intravenous Infusions's Trailing 12-Month Free Cash Flow is GHS0.00 Mil, and Market Cap is GHS0.00 Mil. Therefore, Intravenous Infusions's FCF Yield % for today is 0.00%.

The historical rank and industry rank for Intravenous Infusions's FCF Yield % or its related term are showing as below:

XGHA:IIL's FCF Yield % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: -0.15
* Ranked among companies with meaningful FCF Yield % only.

Intravenous Infusions's FCF Margin % for the quarter that ended in . 20 was 0.00%.

Intravenous Infusions FCF Yield % Historical Data

The historical data trend for Intravenous Infusions's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intravenous Infusions FCF Yield % Chart

Intravenous Infusions Annual Data

Trend

FCF Yield %

Intravenous Infusions Semi-Annual Data

FCF Yield %

Competitive Comparison of Intravenous Infusions's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Intravenous Infusions's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Intravenous Infusions's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Intravenous Infusions's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Intravenous Infusions's FCF Yield % falls into.

Intravenous Infusions FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Intravenous Infusions's FCF Yield % for the fiscal year that ended in . 20 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=		/
	=	N/A%

Intravenous Infusions's annualized FCF Yield % for the quarter that ended in . 20 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=		*	1	/
	=	N/A%

Intravenous Infusions FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Intravenous Infusions FCF Yield % Related Terms

Thank you for viewing the detailed overview of Intravenous Infusions's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Intravenous Infusions (XGHA:IIL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intravenous Infusions Ltd (XGHA:IIL) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Plot 4/7 Blk L, P.O Box KF 63, Effiduase-Koforidua, GHA

Website

https://www.iil.com.gh

Intravenous Infusions Ltd engages in the production of intravenous infusion and small-volume injectables for therapeutic purposes. The product categories are IV fluids, giving sets, and small-volume injectables. The company earns a majority of its revenue from IV fluids. Some of the IV fluids are sodium chloride solutions, dextrose solutions, dextrose saline solutions, and dextran solutions. Small-volume injectables include pethidine injection, magnesium sulphate injection, and quinine injection. Giving sets include plain giving sets, and blood giving sets.